Shandong Head Group Co., Ltd. Class A
SSZSE:00281016.41
CNY
+0.19
(+1.17%)
Shandong Head Group Co., Ltd. Class A
SZSE:002810
(Shenzhen Stock Exchange)
Recent
price
16.41
P/E
ratio
29.82
div
yld
0.26%
ROIC.AI
Capital Structure
CNY
•
in mil. unless spec.Working Capital
CNY
•
in mil. unless spec.Growth Rates
CNY
•
in mil. unless spec.Quarterly Revenue
CNY
•
in mil. unless spec.Quarterly Earnings Per Share
CNY
•
in mil. unless spec.Quarterly Dividends Per Share
CNY
•
in mil. unless spec.- Similar Companies
- Business
- Shandong Head Group Co., Ltd. specializes in the research, development, manufacturing, and sales of cellulose ethers and hydroxypropyl methylcellulose (HPMC) empty capsules. The company’s core products include a broad range of cellulose ether compounds such as Hydroxypropyl Methyl Cellulose (HPMC), Methyl Cellulose (MC), Hydroxyethyl Methyl Cellulose (HEMC), Ethyl Cellulose (EC), Hydroxyethyl Cellulose (HEC), Methyl Hydroxyethyl Cellulose (MHEC), Sodium Carboxymethyl Cellulose (Na-CMC), and Hydroxypropyl Cellulose (HPC). Its production division also manufactures HPMC empty capsules under the brand Caps-Healsee, with an annual capacity exceeding 30 billion capsules. In addition to cellulose ethers and capsules, Shandong Head Group produces chemical engineering equipment including graphite heat exchangers, enamel/glass-lined equipment, PTFE-lined equipment, stainless steel equipment, and silicon carbide equipment used widely in chemical industries. The company serves pharmaceutical, food, and industrial sectors globally with operations extending across China, North America, Europe, and other international markets. Founded in 1991 and headquartered in Shandong, China, the group leverages a vertically integrated supply chain for its products. In terms of recent developments, Shandong Head Group has intensified its global expansion, with a significant investment of approximately USD 80 million to establish a new manufacturing facility in the United States. This facility aims to supply over 20 billion HPMC capsules annually, enhancing the company’s supply chain efficiency, reducing lead times, and improving service to North American customers amid growing demand for vegetarian-friendly capsule solutions. This strategic move supports the company’s long-term vision of localized production while mitigating risks associated with international trade volatility. Additionally, Shandong Head Group has forged exclusive partnerships with distributors like Univar Solutions to strengthen its presence in European markets and boost cellulose ether supply. The company has also focused on upgrading R&D capabilities, expanding production capacity to reach an estimated 75,000 tons per year for cellulose ethers and 35 billion capsules per year, thus solidifying its position as a leading global manufacturer in its categories. These initiatives reflect the group’s commitment to sustainable growth and enhanced competitiveness on a global scale. Overall, Shandong Head Group operates mainly within the cellulose ether and pharmaceutical capsule manufacturing industry segments, targeting pharmaceutical, food, and industrial clients worldwide. It maintains a robust production and R&D infrastructure, with subsidiaries including SD Head USA to support North American operations and various partnerships facilitating European market growth. Its strategic expansion efforts, including new U.S. manufacturing capacity and enhanced global partnerships, position the company for continued leadership in both the cellulose ether chemical market and the specialized vegetarian capsule sector. This comprehensive profile underscores Shandong Head Group’s role as an integrated global cellulose ether chemical and capsule manufacturer, founded in 1991 and headquartered in Shandong, China, with significant recent operational expansions and ongoing strategic investments to extend its global footprint and production capabilities.